Results 91 to 100 of about 169,272 (157)

Eosinophilic mucus diseases

Allergology International
Eosinophilic inflammation is primarily characterized by type 2 immune responses against parasitic organisms. In the contemporary human being especially in developed countries, eosinophilic inflammation is strongly associated with allergic/sterile ...
Misaki Arima, Keisuke Ito, Tomoe Abe, Tsuyoshi Oguma, Koichiro Asano, Manali Mukherjee, Shigeharu Ueki   +6 more
doaj   +1 more source

Publication Only

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis

, 1995
Invasive pulmonary aspergillosis is a frequent complication in immunocompromised patients. The role of the prolonged use of steroids in predisposing to invasive aspergillosis has been recognized, but exceptionally described in asthmatic patients.
A. Ganassini, CAZZADORI, Angelo Antonio
core   +1 more source

Successful treatment with inhaled corticosteroid/long-acting β₂-agonist in a case of allergic bronchopulmonary mycosis caused by Schizophyllumcommune. [PDF]

Respir Med Case Rep, 2023
Sekiya M, Sakamoto S, Sekiguchi R, Sadamoto S, Sasaki M, Kamei K, Shibuya K, Kishi K.   +7 more
europepmc   +1 more source

Allergic Bronchopulmonary Aspergillosis

, 2016
Allergic bronchopulmonary aspergillosis (ABPA), a progressive fungal allergic lung disease, is a common complication of asthma or cystic fibrosis. Although ABPA has been recognized since the 1950s, recent research has underscored the importance of Th2 ...
Caroline U. A. Okorie, Caroline Okorie, Michael C. Tracy, Michael Tracy, Elizabeth A. Foley, Richard Moss, Richard B. Moss, Elizabeth Foley   +7 more
core   +1 more source

Allergic bronchopulmonary aspergillosis manifesting as recurrent pneumonia in an adolescent: a case report

, 2020
Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder caused by hypersensi- tivity to Aspergillus fumigatus. The diagnosis is based on sensitization to Aspergillus, associated with clinical, immunological and radiological ...
Arturi, Elisa, L. Pecoraro, M. Piazza, A. Bodini, G. Piacentini, CECCHIN, VANESSA, M. O. Aricò   +6 more
core   +1 more source

Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

, 2018
Moshe Ashkenazi,1,2 Saray Sity,2 Ifat Sarouk,1,2 Bat El Bar Aluma,1,2 Adi Dagan,1,2 Yael Bezalel,1,2 Lea Bentur3 Kris De Boeck,4 Ori Efrati1,2 1Pediatric Pulmonology and National CF Center,
Sarouk I, Bentur L, Bar Aluma BE, De Boeck K, Efrati O, Bezalel Y, Ashkenazi M, Sity S, Dagan A   +8 more
core  

Proposal and Verification of New Revised Criteria for ABPA/ABPM Diagnosis

Journal of Asthma and Allergy
Runjin Cai,1,2,* Huan Ge,1,2,* Bin Liu,3,* Yuling Tang,4,* Jun Wang,5,* Xuemei Chen,1,2 Bing Liu,3,6 Xinyue Hu,1,2 Shuanglinzi Deng,1,2 Hui Li,4 Lixue Dai,5 Jiale Tang,1,2 Chendong Wu,1,2 Xiaoxiao Gong,1,2 Guo Wang,1,2 Xiaozhao Li,2,7
Cai R, Ge H, Liu B, Tang Y, Wang J, Chen X, Liu B, Hu X, Deng S, Li H, Dai L, Tang J, Wu C, Gong X, Wang G, Li X, Feng J   +16 more
doaj  

Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis

Allergology International, 2021
Hiroki Tashiro, Koichiro Takahashi, Yuki Kurihara, Hironori Sadamatsu, Shinya Kimura, Naoko Sueoka-Aragane   +5 more
doaj   +1 more source

Schizophyllum commune-associated allergic bronchopulmonary mycosis in a postoperative lung cancer patient: A case report and comprehensive literature review. [PDF]

Medicine (Baltimore)
Wu N, Liang Y, Yan Q.
europepmc   +1 more source